STOCK TITAN

Freshpet Financials

FRPT
FY2025 annual
Revenue $1.1B +13.0% YoY
Net Income $139.1M +196.5% YoY
EPS (Diluted) $2.64 +183.9% YoY
Free Cash Flow $12.4M +137.7% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Freshpet (FRPT) reported $1.1B in revenue for fiscal year 2025, up 13.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FRPT FY2025

Freshpet’s recent inflection comes from gross-margin expansion finally outrunning a still-heavy production build, turning growth into cash.

Operating cash flow was nearly flat at $160.6M versus $154.3M in FY2024, so FY2025’s free-cash-flow turn did not come from a dramatic cash-earnings surge. Instead, easing capital intensity did the work: lower capital spending moved free cash flow from -$32.8M to $12.4M, showing the expansion build-out is becoming easier to fund internally.

From FY2023 to FY2025, gross margin widened from 32.7% to 40.8% while the SG&A burden eased, so each sales dollar now leaves much more room for profit after overhead. The move to a 6.9% operating margin looks like fixed costs are being absorbed better, not just that revenue is higher.

FY2025 net income ran well ahead of operating profit, at $139.1M versus $75.7M. A $68.4M tax benefit helped create that spread, so the cleaner signal is that the business now pairs positive operating profit with more than $160M of operating cash and little need for new financing.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 54 / 100
Financial Health Score 54/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Freshpet's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
38

Freshpet has an operating margin of 6.9%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 38/100, indicating healthy but not exceptional operating efficiency. This is up from 3.9% the prior year.

Growth
82

Freshpet's revenue grew 13.0% year-over-year to $1.1B, a solid pace of expansion. This earns a growth score of 82/100.

Leverage
61

Freshpet has a moderate D/E ratio of 0.47. This balance of debt and equity financing earns a leverage score of 61/100.

Liquidity
91

With a current ratio of 5.54, Freshpet holds $5.54 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.

Cash Flow
20

While Freshpet generated $160.6M in operating cash flow, capex of $148.2M consumed most of it, leaving $12.4M in free cash flow. This results in a low score of 20/100, reflecting heavy capital investment rather than weak cash generation.

Returns
32

Freshpet's ROE of 11.5% shows moderate profitability relative to equity, earning a score of 32/100. This is up from 4.5% the prior year.

Altman Z-Score Safe
4.64

Freshpet scores 4.64, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.6B) relative to total liabilities ($569.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

Freshpet passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.15x

For every $1 of reported earnings, Freshpet generates $1.15 in operating cash flow ($160.6M OCF vs $139.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
5.36x

Freshpet earns $5.36 in operating income for every $1 of interest expense ($75.7M vs $14.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.1B
YoY+13.0%
5Y CAGR+28.2%
10Y CAGR+25.2%

Freshpet generated $1.1B in revenue in fiscal year 2025. This represents an increase of 13.0% from the prior year.

EBITDA
$162.1M
YoY+50.8%
5Y CAGR+53.8%
10Y CAGR+45.1%

Freshpet's EBITDA was $162.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 50.8% from the prior year.

Net Income
$139.1M
YoY+196.5%

Freshpet reported $139.1M in net income in fiscal year 2025. This represents an increase of 196.5% from the prior year.

EPS (Diluted)
$2.64
YoY+183.9%

Freshpet earned $2.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 183.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$12.4M
YoY+137.7%

Freshpet generated $12.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 137.7% from the prior year.

Cash & Debt
$278.0M
YoY+3.5%
5Y CAGR+32.8%
10Y CAGR+42.5%

Freshpet held $278.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
49M
YoY+0.6%
5Y CAGR+3.8%
10Y CAGR+3.9%

Freshpet had 49M shares outstanding in fiscal year 2025. This represents an increase of 0.6% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
40.8%
YoY+0.2pp
5Y CAGR-0.9pp
10Y CAGR-6.2pp

Freshpet's gross margin was 40.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin
6.9%
YoY+3.0pp
5Y CAGR+7.5pp
10Y CAGR+10.0pp

Freshpet's operating margin was 6.9% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.

Net Margin
12.6%
YoY+7.8pp
5Y CAGR+13.6pp
10Y CAGR+15.8pp

Freshpet's net profit margin was 12.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.8 percentage points from the prior year.

Return on Equity
11.5%
YoY+7.1pp
5Y CAGR+12.3pp
10Y CAGR+15.1pp

Freshpet's ROE was 11.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.1 percentage points from the prior year.

Capital Allocation

Capital Expenditures
$148.2M
YoY-20.8%
5Y CAGR+1.9%
10Y CAGR+18.6%

Freshpet invested $148.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.8% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

FRPT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FRPT annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Revenue$1.2B$1.1B+13.0%$975.2M+27.2%$766.9M+28.8%$595.3M+39.9%$425.5M+33.5%$318.8M+29.7%$245.9M+27.2%$193.2M+26.8%$152.4M+17.5%$129.7M+11.6%$116.2M+33.9%$86.8M+37.4%$63.2M+45.1%$43.5M
Cost of Revenue$690.3M$652.4M+12.6%$579.2M+12.2%$516.0M+26.1%$409.3M+55.4%$263.3M+41.7%$185.9M+41.2%$131.7M+27.5%$103.2M+29.1%$79.9M+15.3%$69.3M+12.7%$61.5M+38.1%$44.5M+23.9%$36.0M+57.1%$22.9M
Gross Profit$487.0M$449.6M+13.6%$396.0M+57.8%$250.9M+34.9%$186.0M+14.7%$162.1M+22.0%$132.9M+16.4%$114.2M+26.9%$90.0M+24.3%$72.4M+20.0%$60.4M+10.5%$54.6M+29.4%$42.2M+55.3%$27.2M+31.8%$20.6M
R&D ExpensesN/AN/AN/AN/AN/AN/A$800K-33.3%$1.2M+140.0%$500K+75.7%$285K-39.5%$470KN/AN/AN/AN/A
SG&A Expenses$391.6M$374.0M+4.5%$358.0M+27.2%$281.3M+18.2%$238.0M+27.4%$186.8M+38.5%$134.9M+17.9%$114.5M+20.6%$94.9M+26.2%$75.2M+20.1%$62.6M+7.4%$58.3M+20.7%$48.3M+22.0%$39.6M+11.8%$35.4M
Operating Income$95.4M$75.7M+99.1%$38.0M+224.8%-$30.4M+41.4%-$52.0M-110.8%-$24.7M-1134.4%-$2.0M-689.7%-$253K+94.8%-$4.9M-77.6%-$2.8M-24.2%-$2.2M+39.3%-$3.6M+40.0%-$6.1M+50.9%-$12.4M+16.0%-$14.7M
Interest Expense$14.0M$14.1M+15.2%$12.3M-13.0%$14.1M+170.7%$5.2M+80.7%$2.9M+137.8%$1.2M+22.3%$991K+234.8%$296K-67.5%$910K+30.4%$698K+53.6%$455K-90.1%$4.6M+32.1%$3.5M+113.2%$1.6M
Income Tax-$45.2M-$68.4M-11532.1%$598K+184.8%$210K-25.5%$282K+74.1%$162K+149.2%$65K-54.9%$144K+87.0%$77K+2.4%$75K+14.4%$66K+14.3%$58K+37.8%$42K+32.4%$32K-3.8%$33K
Net Income$203.5M$139.1M+196.5%$46.9M+239.6%-$33.6M+43.5%-$59.5M-100.3%-$29.7M-831.6%-$3.2M-130.5%-$1.4M+74.2%-$5.4M-25.8%-$4.3M-34.9%-$3.2M+14.8%-$3.7M+90.1%-$37.3M-72.2%-$21.7M-16.2%-$18.7M
EPS (Diluted)$2.64+183.9%$0.93+232.9%-$0.70+45.7%-$1.29-87.0%-$0.69-762.5%-$0.08-100.0%-$0.04+73.3%-$0.15-25.0%-$0.12-33.3%-$0.09+18.2%-$0.11-$9.63-$2.91-13.7%-$2.56

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

FRPT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FRPT annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Total Assets$1.8B+12.9%$1.6B+7.5%$1.5B+30.1%$1.1B+43.5%$784.4M+80.6%$434.4M+84.0%$236.1M+68.7%$140.0M+4.5%$133.9M+5.9%$126.5M+11.8%$113.1M+0.6%$112.5M+79.6%$62.6MN/A
Current Assets$435.7M-0.3%$437.0M+2.3%$427.3M+63.1%$262.0M+74.3%$150.3M+37.8%$109.1M+100.8%$54.3M+75.5%$31.0M+14.8%$27.0M+40.1%$19.2M-24.2%$25.4M-49.4%$50.2M+331.9%$11.6MN/A
Cash & Equivalents$278.0M+3.5%$268.6M-9.5%$296.9M+123.7%$132.7M+82.4%$72.8M+8.2%$67.2M+610.0%$9.5M+25.4%$7.6M+245.9%$2.2M-44.1%$3.9M-51.3%$8.0M-77.9%$36.3M+1383.1%$2.4M+49.7%$1.6M
Inventory$76.8M-5.0%$80.8M+27.8%$63.2M+8.5%$58.3M+63.9%$35.6M+86.1%$19.1M+52.4%$12.5M+34.6%$9.3M-7.9%$10.1M+87.3%$5.4M-21.2%$6.9M-6.3%$7.3M+32.7%$5.5MN/A
Accounts Receivable$63.8M-6.8%$68.4M+20.6%$56.8M-1.4%$57.6M+65.5%$34.8M+88.6%$18.4M-0.8%$18.6M+50.7%$12.3M-3.1%$12.7M+43.2%$8.9M+26.4%$7.0M+31.2%$5.4M+53.3%$3.5MN/A
Total Liabilities$569.1M+9.5%$519.5M+1.7%$511.0M+444.7%$93.8M+45.1%$64.7M+60.8%$40.2M-61.6%$104.9M+467.1%$18.5M+8.8%$17.0M-9.0%$18.7M+104.1%$9.1M+0.9%$9.1M-95.3%$193.7MN/A
Current Liabilities$78.6M-20.5%$98.9M+10.8%$89.2M-0.4%$89.6M+52.0%$58.9M+78.0%$33.1M-21.1%$42.0M+130.5%$18.2M+9.1%$16.7M-10.6%$18.7M+104.1%$9.1M+0.9%$9.1M+10.7%$8.2MN/A
Long-Term DebtN/AN/AN/AN/A$0$0-100.0%$54.5MN/AN/AN/AN/AN/A$1.1MN/A
Total Equity$1.2B+14.5%$1.1B+10.7%$953.5M-7.6%$1.0B+43.3%$719.8M+82.6%$394.2M+200.3%$131.3M+8.1%$121.5M+3.9%$116.9M+8.5%$107.8M+3.7%$104.0M+0.5%$103.4M+178.9%-$131.1M-28.7%-$101.8M
Retained Earnings-$142.7M+49.4%-$281.8M+14.3%-$328.7M-11.4%-$295.1M-25.2%-$235.6M-14.4%-$205.9M-1.6%-$202.7M-0.7%-$201.4M-2.7%-$196.0M-2.2%-$191.7M-1.7%-$188.6M-2.0%-$184.9M-25.3%-$147.5MN/A

Not reported in any period shown, so not listed: Goodwill.

FRPT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FRPT annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Operating Cash Flow$206.6M$160.6M+4.1%$154.3M+103.2%$75.9M+275.7%-$43.2M-6781.1%$647K-96.9%$21.2M+29.9%$16.3M-12.2%$18.6M+80.9%$10.3M-19.8%$12.8M+89.9%$6.7M+184.0%-$8.0M+28.6%-$11.2M-29.0%-$8.7M
Capital Expenditures$145.6M$148.2M-20.8%$187.1M-21.7%$239.1M+3.9%$230.1M-28.6%$322.1M+139.4%$134.6M+90.5%$70.6M+334.0%$16.3M+25.1%$13.0M-56.6%$30.0M+10.9%$27.0M+57.7%$17.1M-30.5%$24.6M-6.6%$26.4M
Free Cash Flow$61.0M$12.4M+137.7%-$32.8M+79.9%-$163.2M+40.3%-$273.3M+15.0%-$321.5M-183.5%-$113.4M-108.7%-$54.3M-2460.5%$2.3M+184.2%-$2.7M+84.1%-$17.2M+15.4%-$20.3M+19.4%-$25.2M+29.9%-$35.9M-2.2%-$35.1M
Investing Cash Flow-$45.6M-$148.2M+20.8%-$187.1M+21.7%-$239.1M-2.5%-$233.4M+27.5%-$322.1M-98.3%-$162.5M-130.0%-$70.6M-334.0%-$16.3M-25.1%-$13.0M+51.3%-$26.7MN/AN/AN/AN/A
Financing Cash Flow-$53.9M-$3.0M-166.5%$4.6M-98.6%$327.3M-2.7%$336.5M+2.9%$327.0M+64.3%$199.0M+254.0%$56.2M+1732.3%$3.1M+204.0%$1.0M-89.7%$9.8MN/AN/AN/AN/A
Share BuybacksN/AN/AN/AN/AN/AN/AN/AN/A$256KN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

FRPT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

FRPT annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Gross Margin40.8%+0.2pp40.6%+7.9pp32.7%+1.5pp31.3%-6.9pp38.1%-3.6pp41.7%-4.8pp46.5%-0.1pp46.6%-1.0pp47.5%+1.0pp46.5%-0.5pp47.0%-1.6pp48.7%+5.6pp43.1%-4.4pp47.4%
Operating Margin6.9%+3.0pp3.9%+7.9pp-4.0%+4.8pp-8.7%-2.9pp-5.8%-5.2pp-0.6%-0.5pp-0.1%+2.4pp-2.5%-0.7pp-1.8%-0.1pp-1.7%+1.4pp-3.1%+3.9pp-7.0%+12.6pp-19.6%+14.3pp-33.9%
Net Margin12.6%+7.8pp4.8%+9.2pp-4.4%+5.6pp-10.0%-3.0pp-7.0%-6.0pp-1.0%-0.4pp-0.6%+2.2pp-2.8%0.0pp-2.8%-0.4pp-2.4%+0.7pp-3.2%+39.9pp-43.0%-8.7pp-34.3%+8.5pp-42.9%
Return on Equity11.5%+7.1pp4.5%+8.0pp-3.5%+2.2pp-5.8%-1.6pp-4.1%-3.3pp-0.8%+0.2pp-1.1%+3.4pp-4.4%-0.8pp-3.6%-0.7pp-2.9%+0.6pp-3.6%+32.5pp-36.1%N/AN/A
Return on Assets7.8%+4.8pp3.0%+5.3pp-2.3%+3.0pp-5.3%-1.5pp-3.8%-3.1pp-0.7%-0.1pp-0.6%+3.2pp-3.8%-0.6pp-3.2%-0.7pp-2.5%+0.8pp-3.3%+29.9pp-33.2%+1.4pp-34.6%N/A
Current Ratio5.54+1.1x4.42-0.4x4.79+1.9x2.92+0.4x2.55-0.7x3.29+2.0x1.29-0.4x1.70+0.1x1.61+0.6x1.03-1.7x2.78-2.8x5.54+4.1x1.42N/A
Debt-to-Equity0.470.0x0.490.0x0.54+0.4x0.09+0.1x0.000.0x0.00-0.4x0.41+0.3x0.150.0x0.150.0x0.17+0.1x0.090.0x0.09N/AN/A
FCF Margin1.1%+4.5pp-3.4%+17.9pp-21.3%+24.6pp-45.9%+29.6pp-75.5%-40.0pp-35.6%-13.5pp-22.1%-23.3pp1.2%+3.0pp-1.8%+11.4pp-13.2%+4.2pp-17.4%+11.5pp-29.0%+27.8pp-56.8%+23.9pp-80.7%

Similar Companies

Frequently Asked Questions

What is Freshpet's annual revenue?

Freshpet (FRPT) reported $1.1B in total revenue for fiscal year 2025. This represents a 13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Freshpet's revenue growing?

Freshpet (FRPT) revenue grew by 13.0% year-over-year, from $975.2M to $1.1B in fiscal year 2025.

Is Freshpet profitable?

Yes, Freshpet (FRPT) reported a net income of $139.1M in fiscal year 2025, with a net profit margin of 12.6%.

Freshpet (FRPT) reported diluted earnings per share of $2.64 for fiscal year 2025. This represents a 183.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Freshpet (FRPT) had EBITDA of $162.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Freshpet (FRPT) had a gross margin of 40.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Freshpet (FRPT) had an operating margin of 6.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Freshpet (FRPT) had a net profit margin of 12.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Freshpet (FRPT) has a return on equity of 11.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Freshpet (FRPT) generated $12.4M in free cash flow during fiscal year 2025. This represents a 137.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Freshpet (FRPT) generated $160.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Freshpet (FRPT) had $1.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Freshpet (FRPT) invested $148.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Freshpet (FRPT) had 49M shares outstanding as of fiscal year 2025.

Freshpet (FRPT) had a current ratio of 5.54 as of fiscal year 2025, which is generally considered healthy.

Freshpet (FRPT) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Freshpet (FRPT) had a return on assets of 7.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Freshpet (FRPT) has an Altman Z-Score of 4.64, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Freshpet (FRPT) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Freshpet (FRPT) has an earnings quality ratio of 1.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Freshpet (FRPT) has an interest coverage ratio of 5.36x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Freshpet (FRPT) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top